Implication of the toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis-Reference-Cited by-同舟云学术

Implication of the toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis

Published:2011-10 Issue:4 Volume:70 Page:634-645
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Bustamante Marta F.,Fissolo Nicolás,Río Jordi,Espejo Carmen,Costa Carme,Mansilla María José,Lizasoain Ignacio,Angeles Moro María,Carmen Edo Mari,Montalban Xavier,Comabella Manuel

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference20 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial;The Interferon β Multiple Sclerosis Study Group;Neurology,1993

2. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG);Jacobs;Ann Neurol,1996

3. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis;PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group;Lancet,1998

4. Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials;Rio;Ann Neurol,2002

5. A type I interferon signature in monocytes is associated with poor response to interferon-b in multiple sclerosis;Comabella;Brain,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review);Medicine International;2023-08-17

2. Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta;Mutation Research/Reviews in Mutation Research;2020-07

3. Higher Levels of Serum TLR2 and TLR4 in Patients with Hashimoto's Thyroiditis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2020-01-07

4. Spectrum of Microbial Sequences and a Bacterial Cell Wall Antigen in Primary Demyelination Brain Specimens Obtained from Living Patients;Scientific Reports;2019-02-04

5. Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy;European Journal of Heart Failure;2017-03-31